B
Ben Cromarty
Researcher at The Advisory Board Company
Publications - 2
Citations - 1111
Ben Cromarty is an academic researcher from The Advisory Board Company. The author has contributed to research in topics: Tenofovir alafenamide. The author has an hindex of 1, co-authored 2 publications receiving 1105 citations.
Papers
More filters
Journal ArticleDOI
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
Brian Gazzard,Jane Anderson,Abdel Babiker,Marta Boffito,Gary Brook,Gary Brough,Duncan Churchill,Ben Cromarty,Satyajit Das,Martin Fisher,Andrew L. Freedman,Anna Maria Geretti,Margaret A. Johnson,Saye Khoo,Clifford Leen,Devaki Nair,Barry Peters,Andrew N. Phillips,Deenan Pillay,Anton Pozniak,John P. Walsh,Ed Wilkins,Ian S. Williams,Matthew Williams,M Youle +24 more
TL;DR: The 2008 BHIVA Guidelines have been updated to incorporate all the new relevant information since the last iteration and all the peer-reviewed publications and important, potentially treatment-changing abstracts from the last 2 years have been reviewed.
Journal ArticleDOI
Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate.
L Campbell,Birgit Barbini,Keith Burling,Ben Cromarty,Lisa Hamzah,Margaret Johnson,Rachael Jones,Amanda Samarawickrama,Deborah Williams,Alan Winston,Frank A. Post,Fanta trial team +11 more
TL;DR: In this paper, the authors used multilevel mixed-effects linear regression models to investigate whether TAF can be safely administered to individuals who experienced renal tubulopathy (PRT) on TDF.